Andrew Lees

Rivastigmine for Dementia Associated with Parkinson's Disease

Murat Emre, Dag Aarsland, Alberto Albanese et al. · New England Journal of Medicine · 2004 · 1.2K citations · Full text

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset

Peter Jenner, N.M.J. Rupniak, Sarah Rose et al. · Neuroscience Letters · 1984 · 324 citations

Medicine, Parkinson Disease, Neuropharmacology +5

Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial

Adam L. Boxer, Anthony E. Lang, Murray Grossman et al. · The Lancet Neurology · 2014 · 282 citations · Full text

Placebo-controlled Phase 2/3, Progressive Supranuclear Palsy, Rehabilitation +3

<i>SNCA</i> variants are associated with increased risk for multiple system atrophy

Sonja W. Scholz, Henry Houlden, Claudia Schulte et al. · Annals of Neurology · 2009 · 279 citations

Linkage disequilibrium fine mapping and haplotype association analysis of the <i>tau</i> gene in progressive supranuclear palsy and corticobasal degeneration

Alan Pittman, A. J. W. Myers, Patrick M. Abou‐Sleiman et al. · Journal of Medical Genetics · 2005 · 262 citations · Full text